Found: 5
Select item for more details and to access through your institution.
Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024.
- Published in:
- Eurosurveillance (15607917), 2024, v. 29, n. 8, p. 1, doi. 10.2807/1560-7917.ES.2024.29.8.2400089
- By:
- Publication type:
- Article
Clinical isolates of ST131 blaOXA-244-positive Escherichia coli, Italy, December 2022 to July 2023.
- Published in:
- Eurosurveillance (15607917), 2024, v. 29, n. 8, p. 10, doi. 10.2807/1560-7917.ES.2024.29.8.2400073
- By:
- Publication type:
- Article
Wastewater-based reproduction numbers and projections of COVID-19 cases in three areas in Japan, November 2021 to December 2022.
- Published in:
- Eurosurveillance (15607917), 2024, v. 29, n. 8, p. 17, doi. 10.2807/1560-7917.ES.2024.29.8.2300277
- By:
- Publication type:
- Article
Measuring waning protection from seasonal influenza vaccination during nine influenza seasons, Ontario, Canada, 2010/11 to 2018/19.
- Published in:
- Eurosurveillance (15607917), 2024, v. 29, n. 8, p. 29, doi. 10.2807/1560-7917.ES.2024.29.8.2300239
- By:
- Publication type:
- Article
Application of the screening method for estimating COVID-19 vaccine effectiveness using routine surveillance data: Germany's experience during the COVID-19 pandemic, July 2021 to March 2023.
- Published in:
- Eurosurveillance (15607917), 2024, v. 29, n. 8, p. 40, doi. 10.2807/1560-7917.ES.2023.29.8.2300329
- By:
- Publication type:
- Article